Cargando…

The Effect of Lung Resection for NSCLC on Circulating Immune Cells: A Pilot Study

This pilot study sought to evaluate the circulating levels of immune cells, particularly regulatory T-cell (Treg) subsets, before and after lung resection for non-small cell lung cancer. Twenty-five patients consented and had specimens collected. Initially, peripheral blood of 21 patients was collec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Phillips, Joseph D., Fay, Kayla A., Bergeron, Alan J., Zhang, Peisheng, Mielcarz, Daniel W., Calkins, Andrew M., Searles, Tyler G., Christensen, Brock C., Finley, David J., Turk, Mary Jo, Channon, Jacqueline Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217048/ https://www.ncbi.nlm.nih.gov/pubmed/37232845 http://dx.doi.org/10.3390/curroncol30050387

Ejemplares similares

Circulating Tumor Cells Detected in the Tumor-Draining Pulmonary Vein Are Associated with Disease Recurrence after Surgical Resection of NSCLC
por: Crosbie, Phil A.J., et al.
Publicado: (2016)

Long-Term Recurrence of Completely Resected NSCLC
por: Masago, Katsuhiro, et al.
Publicado: (2020)

Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC
por: Goh, Kah Yee, et al.
Publicado: (2023)

Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC
por: Antonoff, Mara B., et al.
Publicado: (2022)

Update on adjuvant therapy in completely resected NSCLC patients
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Safety and Immune Effects of Blocking CD40 Ligand in Multiple Sclerosis
por: Fadul, Camilo E., et al.
Publicado: (2021)

Circulating Plasma MicroRNAs As Diagnostic Markers for NSCLC
por: Hou, Jinpao, et al.
Publicado: (2016)

Pulmonary resection for NSCLC in octogenarians: a single center experience
por: Di Russo, S, et al.
Publicado: (2011)

Surgical Insights Are Essential to Integration of Immune Therapy in Resectable NSCLC
por: Donington, Jessica S.
Publicado: (2021)

Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC
por: Petersen, Lars F., et al.
Publicado: (2017)

Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC
por: Lee, Jay M., et al.
Publicado: (2021)

Increasing shareholder focus: the repercussions of the 2015 corporate governance reform in Japan
por: Mielcarz, Paweł, et al.
Publicado: (2021)

Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
por: Borghetti, Paolo, et al.
Publicado: (2022)

Residing in a food desert is associated with an increased risk of readmission following esophagectomy for cancer
por: Fay, Kayla A., et al.
Publicado: (2022)

Assessment of the Mutational Status of NSCLC Using Hypermetabolic Circulating Tumor Cells
por: Turetta, Matteo, et al.
Publicado: (2018)

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
por: Kejík, Zdeněk, et al.
Publicado: (2021)

Postoperative atrial fibrillation prophylaxis using a novel amiodarone order set
por: Phillips, Joseph D., et al.
Publicado: (2020)

PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC
por: Ameratunga, Malaka, et al.
Publicado: (2016)

Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC
por: Katsurada, Naoko, et al.
Publicado: (2020)

Prognostic value of ESR2 expression on adjuvant chemotherapy in completely resected NSCLC
por: Yu, Hongliang, et al.
Publicado: (2020)

Immunotherapy and Vaccination in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)
por: Chiu, Li-Chung, et al.
Publicado: (2021)

Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC of Never Smokers
por: Ruel, Louis-Jacques, et al.
Publicado: (2022)

Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC
por: Lee, Jay M., et al.
Publicado: (2023)

Occult lymph node metastasis is not a favorable factor for resected NSCLC patients
por: Cai, Jing-Sheng, et al.
Publicado: (2023)

Protective CD8 Memory T Cell Responses to Mouse Melanoma Are Generated in the Absence of CD4 T Cell Help
por: Côté, Anik L., et al.
Publicado: (2011)

Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC Patients
por: Catarino, Raquel, et al.
Publicado: (2012)

Rescue of Non-Informative Circulating Tumor DNA to Monitor the Mutational Landscape in NSCLC
por: Mayer, Stefanie, et al.
Publicado: (2020)

Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors
por: Castello, Angelo, et al.
Publicado: (2020)

Epithelial circulating tumor cells with a heterogeneous phenotype are associated with metastasis in NSCLC
por: Zhang, Yujuan, et al.
Publicado: (2021)

Cerebrospinal fluid circulating tumor DNA depicts profiling of brain metastasis in NSCLC
por: Wu, Jun, et al.
Publicado: (2022)

DNA Methylation Changes in Regional Lung Macrophages Are Associated with Metabolic Differences
por: Armstrong, David A., et al.
Publicado: (2019)

Does Every Necrotizing Granulomatous Inflammation Identified by NSCLC Resection Material Require Treatment?
por: Yakar, Fatih, et al.
Publicado: (2016)

Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC
por: Salvi, Rosario, et al.
Publicado: (2016)

Influence of Vitamins on Secondary Reactive Oxygen Species Production in Sera of Patients with Resectable NSCLC
por: Patrice, Thierry, et al.
Publicado: (2016)

Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm
por: Huang, Chien‐Sheng, et al.
Publicado: (2020)

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Qiu, Bin, et al.
Publicado: (2021)

Lobe-Specific Analysis of Sublobar Lung Resection for NSCLC Patients with Tumors ≤ 2 cm
por: Lei, Xi, et al.
Publicado: (2022)

Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I–IIIA
por: Wallerek, Sandra, et al.
Publicado: (2015)

Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC
por: Gallina, Filippo Tommaso, et al.
Publicado: (2023)

EGFR mutation analysis on circulating free DNA in NSCLC: a single-center experience
por: Ianza, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ahvdtfogh6im6strifpnp57287